Frontlight ResearchEarly access
Taking people in United StatesNo phase
Collects blood and liver samples to study liver diseases
Stores blood and liver samples for future research on liver disease.
Key facts
- Who runs it
- State University of New York at Buffalo
- Where
- Buffalo, United StatesSee the site
- Trial code
- Registry title
- Blood Collection Biorepository for Liver Disease Research
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- Jul 2013
- Expected to end
- Dec 2099
- Type of study
- Observational
- Record updated
- 8 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is collecting blood samples from people with or without liver disease. The samples will be stored for future liver research.
- Age
- 7 Years and older
- Sex
- All sexes can join.
- Disease stage
- People with liver diseases such as viral hepatitis, liver cancer or NASH can join. People without liver disease can also join as comparison samples.
Main reasons for not taking part
- Adults who cannot give consent
- Infants
- Pregnant women
- Prisoners
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples
- Children and teenagers will be special populations considered in this protocol
Who cannot take part
- Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study
Where in United States
- University at Buffalo, Buffalo General Medical CenterBuffalo, United StatesContact: Barbara Bauer, BATaking people
About the trial
What the trial wants to find out
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases
- Plain-language title
- Collects blood and liver samples to study liver diseasesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 October 2026